Research Highlight | Published:


Gene therapy to inhibit CaMKII in CPVT

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


    Original article

    1. Bezzerides, V. J. et al. Gene therapy for catecholaminergic polymorphic ventricular tachycardia by inhibition of Ca2+/calmodulin-dependent kinase II. Circulation (2019)

    Further reading

    1. Bongianino, R. & Priori, S. G. Gene therapy to treat cardiac arrhythmias. Nat. Rev. Cardiol. 12, 531–546 (2015)

    Download references

    Author information

    Correspondence to Gregory B. Lim.

    Rights and permissions

    Reprints and Permissions

    About this article